Earnings Call · Q2 FY2026·2026-08-04

Q2 26EPS +50.00%·Rev n/aQ1 26EPS +12.93%·Rev n/aQ4 25EPS +1.49%·Rev n/aQ3 25EPS +9.79%·Rev n/a⚠ consensus missing

Merck & Co., Inc. MRK

Shirley — Conference Operator

Peter Dannenbaum — Senior Vice President, Investor Relations

Rob Davis — Chairman and Chief Executive Officer

Caroline Litchfield — Chief Financial Officer

Dr. Dean Li — President of Research Labs

+0.2%1d on move date

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more MRK calls or request research access.

More MRK calls Browse calls Request research access